New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
07:21 EDTJAZZJazz Pharmaceuticals price target raised to $87 from $76 at Lazard Capital
Lazard Capital raised its price target fort Jazz Pharmaceuticals citing expectations for robust Xyrem revenue growth and keeps a Buy rating on the stock.
News For JAZZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
10:43 EDTJAZZJazz Pharmaceuticals management to meet with FBR Capital
Meeting to be held in New York on December 1 hosted by FBR Capital.
November 18, 2014
07:37 EDTJAZZStifel to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use